The Pharmaletter

One To Watch

nucana_company

NuCana

NuCana is a clinical-stage biopharmaceutical company focused on improving treatment outcomes for patients with cancer by applying phosphoramidate chemistry technology to change widely prescribed chemotherapy agents into more effective and safer medicines.

Using proprietary ProTide technology, the company is developing new medicines designed to overcome cancer resistance mechanisms and generate higher concentrations of anti-cancer metabolites in cancer cells.

Want to Update your Company's Profile?


More NuCana news >